Altimmune, Inc. Annual Income Tax Expense (Benefit) in USD from 2012 to 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Altimmune, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2022.
- Altimmune, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
- Altimmune, Inc. annual Income Tax Expense (Benefit) for 2022 was -$197K.
- Altimmune, Inc. annual Income Tax Expense (Benefit) for 2020 was -$5.42M, a 9160% decline from 2019.
- Altimmune, Inc. annual Income Tax Expense (Benefit) for 2019 was -$58.5K, a 99% increase from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)